#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Loss of consciousness Diffuse large B-cell lymphoma recurrent Pouchitis Hypochondroplasia Malignant peritoneal neoplasm Alagille syndrome Hyperadrenocorticism Allogenic stem cell transplantation Pseudoxanthoma elasticum Glioma Philadelphia positive chronic myeloid leukaemia Leiomyosarcoma recurrent Still's disease Congenital generalised lipodystrophy Ovarian cancer More trials…

    Learn about Rare Diseases

    Immunodeficiency congenital – Diagnostics Haemophilia A without inhibitors – Life with Disease Soft tissue sarcoma – Basic Information Idiopathic inflammatory myopathy – Life with Disease Methylmalonic acidaemia – Life with Disease Angelman’s syndrome Progressive supranuclear palsy – Treatment Leukoencephalopathy – Treatment Friedreich’s ataxia – Diagnostics Congenital nephrogenic diabetes insipidus – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    R3R01 Cusatuzumab Gsk6097608 IPN01195 Etravirine Maraviroc Adapalene Plerixafor Favezelimab Iptacopan Nirmatrelvir Bi 706321 Rintatolimod D-Biotin Galcanezumab E.coli Polysaccharide Etoposide Phosphate Hydroxi-Methionine Calcium Artemisia Vulgaris Doxylamine Hydrogen Succinate More therapies…

    Learn about Your Condition

    Thyroid mass Craniosynostosis Alveolar proteinosis Deafness traumatic Primary hyperoxaluria Anogenital warts Osteomyelitis acute Diphtheria Myositis Chronic disease Viral infection Post-traumatic stress disorder Vascular malformation Mitochondrial myopathy Migraine More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study of bitopertin to improve sunlight tolerance in adults with erythropoietic protoporphyria or X-linked protoporphyria

    Not recruiting

    3 1
    Belgium France Germany Ireland Italy The Netherlands +3

  • Study comparing RO7795081 and semaglutide with placebo in adults with type 2 diabetes mellitus

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • RO7795081
    • Semaglutide
    Hungary Poland Spain

  • Comparing weekly insulin icodec and daily insulin glargine with insulin aspart in adults with type 1 diabetes: a 26-week study of blood sugar control

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Insulin Glargine
    • Insulin Icodec
    Germany Poland Romania Slovakia

  • Study of cagrilintide for weight reduction in adults with overweight or obesity when combined with lifestyle changes

    Not recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Cagrilintide
    France Germany Italy Norway Poland

  • Study of vicadrostat and empagliflozin given together or separately in people with chronic kidney disease to test safety and effectiveness

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Bi 690517
    • Empagliflozin
    Belgium Czechia France Germany Italy The Netherlands +2

  • Study of Orforglipron for Weight Management in People with Obesity or Overweight, With or Without Type 2 Diabetes

    Not recruiting

    3 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Obesity
    • Overweight
    Czechia Germany
Previous Page
1 … 34 35 36 37 38 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!